Reducing cardiovascular risk: an emphasis on rosuvastatin
Rosuvastatin is one of the most frequently prescribed drugs for primary and secondary prevention of myocardial infarction and stroke. The present article deals with the main studies confirming the effectiveness of rosuvastatin in patients with different cardiovascular risks.
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IP Morozov P.V.
2017-11-01
|
| Series: | Системные гипертензии |
| Subjects: | |
| Online Access: | http://syst-hypertension.ru/en/archive/2017/vol-14-4-2017/reducing-cardiovascular-risk-an-emphasis-on-rosuvastatin_1828/ |